Expertise in
9
conditions

Yanqing H. Li

107 Wenhua West Road, 
Jinan, CN 
Expertise in
9
conditions
107 Wenhua West Road, 
Jinan, CN 

Overview

Yanqing Li practices practicing medicine in Jinan, China.

Li is highly rated in 9 conditions, according to our data. Their clinical expertise encompasses Chronic Erosive Gastritis, Helicobacter Pylori Infection, Peptic Ulcer, Colonoscopy, and Endoscopy.

They are actively involved in clinical research, co-authoring 123 peer reviewed articles and participating in 4 clinical trials.

Locations

107 Wenhua West Road, Jinan, 250012, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: May 13, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
Intestinal Microflora in Lung Cancer After Chemotherapy
Intestinal Microflora in Lung Cancer After Chemotherapy
Enrollment Status: Completed
Publish Date: May 23, 2017
Intervention Type: Drug
Study Phase: Phase 1
View 3 Less Clinical Trials

123 Total Publications

Corrigendum to 'Divergent trajectories of inflammatory bowel disease in East, South, South-East and Central Asia: A comprehensive GBD 2021 analysis' [J. Transl. Autoimmun. 11 2025 100325].
Corrigendum to 'Divergent trajectories of inflammatory bowel disease in East, South, South-East and Central Asia: A comprehensive GBD 2021 analysis' [J. Transl. Autoimmun. 11 2025 100325].
Journal: Journal of translational autoimmunity
Published: June 29, 2026

Frequently Asked Questions about Yanqing H. Li

Is Yanqing H. Li a top-rated expert for Chronic Erosive Gastritis?

MediFind is an objective health platform that identifies experts based on real-world data. Yanqing H. Li is classified as an Advanced expert for Chronic Erosive Gastritis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yanqing H. Li participate in research or clinical trials?

Yes. Yanqing H. Li has published 123 articles and abstracts on conditions like Chronic Erosive Gastritis. You can view a list of Yanqing H. Li's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Li's expertise for a condition
ConditionClose
      View All 9 Advanced Conditions
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile